Legal Representation
Attorney
John Paul Oleksiuk
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 7, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Aug 7, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Aug 7, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 20, 2023 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Mar 20, 2023 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Mar 20, 2023 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Mar 9, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 9, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 24, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, diagnostic and therapeutic products and services; Design and development of engineered cells for use in scientific research and drug discovery and development; Providing medical research and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering
Additional Information
Pseudo Mark
ELIXIR
Classification
International Classes
042